Development of novel, water-soluble inhibitors of poly (adenosine 5'-diphosphate ribose) synthetase activity for use in shock and ischemia-reperfusion injury.

Critical care medicine ·Vol. 30 ·No. 5 ·2002-05-00 ·Pages 1163-5

Thiemermann C

Abstract

暂无摘要

MeSH Terms

Animals Enzyme Inhibitors/therapeutic use Phenanthrenes/therapeutic use Poly(ADP-ribose) Polymerase Inhibitors Reperfusion Injury/prevention & control Shock/prevention & control

Chemicals

Enzyme Inhibitors N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride Phenanthrenes Poly(ADP-ribose) Polymerase Inhibitors

Authors & Affiliations

1 authors, click to expand affiliations / ORCID

Thiemermann Christoph

Article Info

Journal

Critical care medicine

Abbr.

Crit Care Med

ISSN

0090-3493

DOI

10.1097/00003246-200205000-00038

Published

2002-05-00

Pages

1163-5

Language

English

Region

United States

NLM ID

0355501

Subset

Corrections

CommentOn

PMID: 12006790

CommentOn

PMID: 12006805

External Links

PubMed source DOI: 10.1097/00003246-200205000-00038 View journal details

Analysis Services

Development of novel, water-soluble inhibitors of poly (adenosine 5'-diphosphate ribose) synthetase activity for use in shock and ischemia-reperfusion injury.

Contact

WeChat Official Account